at James Cook University Hospital are leading a designed to improve understanding of the long-term effects some chemotherapy can have on the heart.
The British Heart Foundation-funded COLLATE study is recruiting 200 patients across several UK hospitals. It will create a registry linking information about anthracycline chemotherapy with blood samples and follow-up health data, an approach believed to be the first of its kind in the UK.
Around 1,000 adults across Durham and Tees Valley receive anthracycline chemotherapy each year. Researchers will use blood tests and additional heart scans to look for biological or genetic markers that could eventually help identify people at greater risk and support more tailored .
